prasugrel

(redirected from Effient)
Also found in: Medical.
Related to Effient: efficient
Translations

prasugrel

n prasugrel m
References in periodicals archive ?
Most recently, he held commercial leadership roles in the launch of multiple specialty pharmaceutical products for the treatment of cardiovascular disease, including RANEXA, EFFIENT, and SAVAYSA.
field force, following the unanticipated failure of a major phase 3 trial of solanezumab, which the company was counting on to offset generic competition for several of its other drags, including Strattera, an attention deficit hyperactivity disorder drag; Cialis, an erectile dysfunction treatment; and cardiovascular medicine Effient.
Tenders are invited for Moei And Fans In Non Residential Buildings Including Operation And Maintenance Of Water Supply Pump Sets Oh Lines Sub Staion Equipment Street Lighting Fountains And Ac Units Etc At Nisa Cisf Campus Hakimpet Hyderabad During The Year 2016 2017 Sub Head Replacement Of Old Out Lived Burnt Out 400 Watt Mh Lighting Fittings By Energy Effient Led Flood Lighting In Front Of Administrative Building And Quarter Master Store
clot buster; Efient or Effient (prasugrel) is an antiplatelet drug.
Effient [prescribing information], Indianapolis, IN: Eli Lilly and Company; 2015.
Herper cites Eli Lilly's blood thinner Effient as an example of a drug for which the FDA had difficulty convening a panel.
Although in energy effient ("green") regime, the BS's transmit power for masive MIMO may be low enough that the inter-cell interference is drown in thermal noise, the achievable rate for each spatial stream is also low.
These dyes possess high absorption coefficients and low quantum yield, making them effient contrast agents for PA imaging.
Nurture focuses on healthcare environments and how the elements within those environments can help make them more comfortable, effient, and conducive to the healing process for the patient, caregiver, and partner-in-care.
The rating agency referred to a slew of negative developments that cast a shadow over Lilly's very strong credit quality, including the difficult approval and slow reception of its Effient product, the scrapped arzoxifene product for treatment of breast cancer and osteoporosis in the final stage of clinical development and the recently lost lawsuit that challenged Lilly's patent on ADHD-treatment Strattera, increasing the possibility of an earlier entry of a generic into the US market.
Lilly last week said that its sales representatives would tell doctors about a blood test offered by Accumetrics that physically measures clotting ability after patients take anti-platelet drugs like Effient and Plavix.
Drug maker Daiichi Sankyo climbed 51 yen, or over 3 percent, to 1,714 yen after its drug Effient, which prevents blood clots, received U.